Upgrade to SI Premium - Free Trial

JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform Following Acquisition Offer

November 7, 2019 12:40 PM
JMP Securities analyst Liisa Bayko downgraded Achillion Pharmaceuticals (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles